Do texting-while-driving bans work?
Examining the implications of legislation and enforcement on electronic device use while driving
Client
National Academy of SciencesChallenge
Many states, local jurisdictions, and Canadian provinces have laws restricting or banning the use of electronic devices for talking or texting while driving. Because the laws vary among jurisdictions, are they effective in deterring distracted driving and difficult to enforce?
The National Academy of Sciences reached out to Westat to find the answers.
Solution
Westat will examine existing laws and cluster states and Canadian provinces by characteristics of their distracted driving laws and populations.
A sample of 20 locations will receive an in-depth review of their
- Distracted driving laws
- Educational and outreach efforts
- Enforcement strategies
- Legislative challenges and successes
This review will be supplemented by telephone discussions with state and provincial representatives to better understand how their laws were enacted.
We will develop a model and guidance on best practices for developing, educating on, enforcing, and adjudicating legislation.
Results
Presentations and materials developed will identify key factors for crafting and enacting effective legislation.
In addition, different techniques will be identified that can be customized to implement education and enforcement programs that will best resonate with community residents.
Focus Areas
Transportation Transportation SafetyCapabilities
Partnership Engagement Technical Assistance-
Expert Interview
Safeguarding Data Privacy: Innovations at WestatOctober 2025
Protecting the privacy of people who respond to surveys and censuses is a critical responsibility in federal data collection. During the 2010 Decennial Census, the…
-
Expert Interview
Novel Strategies Transform Clinical Trials Into Future OpportunitiesOctober 2025
For the rigorous evaluation of novel medicines, clinical trials are essential to ensure safety and efficacy. However, clinical trials are experiencing turbulent times due to…
-
Expert Interview
Real-World Insights: Nirsevimab’s Protection Against RSV in InfantsSeptember 2025
Each year in the U.S., respiratory syncytial virus, commonly known as RSV, leads to approximately 58,000 to 80,000 hospitalizations among children under age 5. The…